12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Company News  |  Other News

University of California other research news

UCSF researchers and colleagues at Children's Hospital (Boston, Mass.) and Lexigen Pharmaceuticals Corp. (Lexington, Mass.) published in Science an analysis of anti-angiogenic factors in a transgenic mouse model of pancreatic cancer. They found that British Biotech...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >